Detalhe da pesquisa
1.
Landscape of helper and regulatory antitumour CD4+ T cells in melanoma.
Nature
; 605(7910): 532-538, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35508657
2.
Mechanisms of response and resistance to combined decitabine and ipilimumab for advanced myeloid disease.
Blood
; 141(15): 1817-1830, 2023 04 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-36706355
3.
A multi-cohort phase 1b trial of rituximab in combination with immunotherapy doublets in relapsed/refractory follicular lymphoma.
Ann Hematol
; 103(1): 185-198, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37851072
4.
Ipilimumab plus decitabine for patients with MDS or AML in posttransplant or transplant-naïve settings.
Blood
; 141(15): 1884-1888, 2023 04 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-36332187
5.
Preexisting tumor-resident T cells with cytotoxic potential associate with response to neoadjuvant anti-PD-1 in head and neck cancer.
Sci Immunol
; 8(87): eadf4968, 2023 09 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37683037
6.
Expansion, persistence, and efficacy of donor memory-like NK cells infused for posttransplant relapse.
J Clin Invest
; 132(11)2022 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35349491
7.
Reversal of viral and epigenetic HLA class I repression in Merkel cell carcinoma.
J Clin Invest
; 132(13)2022 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35775490
8.
Combining CTLA-4 and angiopoietin-2 blockade in patients with advanced melanoma: a phase I trial.
J Immunother Cancer
; 9(11)2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34772758
9.
Intrinsic Immunogenicity of Small Cell Lung Carcinoma Revealed by Its Cellular Plasticity.
Cancer Discov
; 11(8): 1952-1969, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33707236